Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc. | Cbo & Evp | $12.6M | -$629K | -4.75% | Mar 11, 2024 |
PASG | Passage BIO, Inc. | Director | Sep 30, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|